Overview Financials News + Filings Key Docs Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results
|
Tenaya Therapeutics, Inc.
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/09/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
08/09/2023 |
8-K
| Quarterly results |
06/12/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
05/10/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
05/10/2023 |
8-K
| Quarterly results |
04/27/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
04/27/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
04/17/2023 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
03/08/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
03/08/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
03/08/2023 |
8-K
| Quarterly results |
02/21/2023 |
SC 13D/A
| COLUMN GROUP III, LP reports a 17.8% stake in TENAYA THERAPEUTICS, INC. |
02/14/2023 |
SC 13G/A
| RA CAPITAL MANAGEMENT, L.P. reports a 10% stake in Tenaya Therapeutics, Inc. |
02/14/2023 |
SC 13G/A
| PRICE T ROWE ASSOCIATES INC reports a 6.7% stake in TENAYA THERAPEUTICS INC |
02/09/2023 |
SC 13G/A
| FMR LLC reports a 4.2% stake in TENAYA THERAPEUTICS INC |
12/07/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
12/07/2022 |
SC 13D/A
| Casdin Capital, LLC reports a 9.9% stake in Tenaya Therapeutics, Inc. |
12/01/2022 |
SC 13D
| COLUMN GROUP III, LP reports a 15% stake in TENAYA THERAPEUTICS, INC. |
11/28/2022 |
SC 13D/A
| Casdin Capital, LLC reports a 9.9% stake in Tenaya Therapeutics, Inc. |
11/17/2022 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits Interactive Data |
11/17/2022 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
11/16/2022 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
10/11/2022 |
SC 13G/A
| FMR LLC reports a 7.6% stake in TENAYA THERAPEUTICS INC |
08/18/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
08/17/2022 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
08/10/2022 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
08/10/2022 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
08/10/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
08/10/2022 |
8-K
| Quarterly results |
06/10/2022 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
05/11/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
05/11/2022 |
8-K
| Quarterly results |
|
|
|